Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating TJ101 for safety, pharmacokinetics, and efficacy in advanced/metastatic solid tumors, including non-small cell lung cancer and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer

Drugs mentioned

• TJ101

Snippet

Sponsor: Phrontline Biopharma | Conditions: Lung Cancer (NSCLC), Prostate Cancer | Phase 1 | Status: RECRUITING